MEAI is a novel, non-hallucinogenic neuroplastogen designed to modulate serotonin and dopamine pathways, potentially reducing cravings and supporting long-term recovery. This approach could offer a ...

A pharmaceutical company has issued a recall of hundreds of thousands of blood medication bottles over the presence of a ...

The U.S. Food and Drug Administration has recalled over 580,000 bottles of a blood-pressure drug after finding a potentially ...

"We've greatly misjudged and mis-prioritized the mental health of mothers in general and we've gotten a lot of it wrong." ...

A former prison worker who smuggled drugs into Lebanon Correctional Institution, leading to an inmate's 2023 overdose death, was sentenced to probation. Lindsey Brooke Lucas, 40, of Moraine was ...

"Double double toil and trouble" is a quote from Shakespeare's Macbeth that conjures images of evil witches making potions in ...

Collaboration will leverage AI-powered neural analysis and Compass' expertise in psychedelic drug development to advance new therapies for mental health ...

The Warren Police Department reported officers found counterfeit candy and snacks containing THC and hallucinogenic products ...

Leiden researchers, led by Sebastian Pomplun, have developed a new method to screen hundreds of thousands of molecules for ...